Meet Your Next Milestone
The biopharmaceutical pipeline is growing and the competition is fierce. While established companies are utilizing accelerated development pathways for drug approval, there are a number of new entrants in the market. As a result, the race to gain approval and commercialize new drugs is intense. Consider West - a trusted partner to the world’s top pharmaceutical and biotechnology companies and a leading global manufacturer of high-quality containment for injectable medicines.
Ebook: Key Considerations for Selecting Fill/Finish Manufacturing Technologies
With the growing pipeline of biologics in development and a trend toward smaller batch sizes targeting smaller patient populations, find out what pharmaceutical, biotech companies, and contract development and manufacturing organizations (CDMOs) are doing to ensure product quality and safety, while meeting requirements with advanced manufacturing technologies.
DownloadInformation Sheet: West Ready Pack® Containment Solution
The West Ready Pack® containment solution includes high quality components to protect, store and deliver your drug product. Speed up your time to market and reduce your risk of selecting individual components that may not work well together by choosing the Ready Pack containment solution.
DownloadWhitepaper: Selecting Container Closure Components with Confidence: A Data-driven Approach to Container Closure Integrity
Container closure integrity (CCI) is a critical aspect of drug development. This whitepaper discusses how West is supporting pharmaceutical partners in this critical area to accelerate the selection of a container closure solution that meets the requirements of the modern regulatory landscape.
DownloadBlog: From Concept to Containment and Beyond: 5 Essential Elements of Packaging
Are you making the best packaging decisions? Learn about the 5 essential elements to consider - your drug depends on it.
DownloadEbook: How You Can Cut Through Complexity, Gain Speed and Get Your Drug to the Patient as Soon as Possible
Creating a drug and getting it approved is no small feat, particularly amidst key trends that are reshaping the market. Emerging and established biopharmaceutical company innovators in early-stage drug development have unique challenges and key milestones to achieve.
DownloadInfographic: Market Dynamics are Driving the Demand for Quicker Drug Development and Approvals
Get the latest details to maximize drug development opportunities and launch activities.
DownloadWhitepaper: Meeting Your Next Milestone: Containment Solutions to Help Emerging Biologic Companies Get Products to the Market Faster
Emerging companies have unique challenges when it comes to bringing an injectable biologic to market. This whitepaper reviews challenges that emerging biologics companies face and presents packaging containment offerings that help mitigate risks and reduce obstacles that slow development.
DownloadWebinar: Primary Packaging for High Value Biologics
Biologics occupy a growing share of the current drug market and drug development pipeline. The high value of new advanced therapies combined with their unique requirements intensifies the need for a reliable container closure system. Innovations in containment technology are now available to address packaging challenges.
View on-demand